Arcturus therapeutics to present at guggenheim securities smid cap biotech conference

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a commercial messenger rna medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the company will participate at a fireside chat hosted by guggenheim securities smid cap biotech conference in new york, on thursday, february 6, 2025, at 10:30 a.m. eastern time. webcast link can be found.
SMID Ratings Summary
SMID Quant Ranking